HilleVax, Inc. (HLVX)
NASDAQ: HLVX · Real-Time Price · USD
2.040
-0.010 (-0.49%)
Jul 8, 2025, 4:00 PM - Market closed
HilleVax Market Cap
HilleVax has a market cap or net worth of $101.69 million as of July 9, 2025. Its market cap has decreased by -83.30% in one year.
Market Cap
101.69M
Enterprise Value
-33.81M
1-Year Change
-83.30%
Ranking
Category
Stock Price
$2.04
Market Cap Chart
Since the IPO on April 29, 2022, HilleVax's market cap has decreased from $538.26M to $101.69M, a decrease of -81.11%. That is a compound annual growth rate of -40.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2025 | 101.69M | 1.85% |
| Dec 31, 2024 | 99.85M | -86.63% |
| Dec 29, 2023 | 746.58M | 25.20% |
| Dec 30, 2022 | 596.32M | 10.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 707.86B |
| Johnson & Johnson | 375.76B |
| AbbVie | 339.40B |
| Novo Nordisk | 308.12B |
| UnitedHealth Group | 277.95B |
| Novartis AG | 240.05B |
| Abbott Laboratories | 233.62B |
| AstraZeneca | 216.19B |